Rights and permissions
About this article
Cite this article
US Affordable Care Act may put 20% of pharma revenue at risk. Pharmacoecon. Outcomes News 637, 11 (2011). https://doi.org/10.2165/00151234-201106370-00034
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106370-00034